Refine by
Coronary Bypass Suppliers & Manufacturers
7 companies found
based inEindhoven, NETHERLANDS
Xeltis is a clinical-stage medical device company pioneering a restorative approach in cardiovascular therapy. RestoreX™, Xeltis technology platform, is the world’s first polymer-based technology designed to enable natural restoration of ...
The XABG device is a restorative, synthetic, electrospun blood vessels for CABG surgery, overtime turning into a living vessel made of patient’s own ...
based inStillwater, MINNESOTA (USA)
Vascudyne is developing, manufacturing and commercializing regenerative acellular in-vitro grown “allograft” tissue. We are visionaries and realists in the right proportions. We are after the holy grail of bringing tissue-engineered medical products ...
Hyperplasia, calcification, foreign body immune response, infection, and atheroma formation are commonly encountered limiting the use of synthetic grafts, with none available for small diameter applications like coronary ...
based inFort Lauderdale, FLORIDA (USA)
SS Innovations International Inc. is a medical technology company founded by Dr. Sudhir Srivastava, a renowned robotic cardiac surgeon. The company specializes in developing advanced robotic systems for surgical procedures. A key innovation is the ...
based inSan Antonio, TEXAS (USA)
Voss Medial Products introduced our first product, the Prone Positioner™ in 1985. The Prone Positioner™ is priced 40% below similar devices and requires no additional hardware. It has been used safely and effectively in more cases than any other ...
HE VM/CV Coronary By-Pass Marker: Easier to use. Easier to locate and remove. The VM/CV Coronary By-Pass Graft Marker provides a blue, radiopaque marker that is easier to locate, cut, bend and remove and is suitable for patients requiring ...
based inLivermore, CALIFORNIA (USA)
Advanced Bifurcation Systems has disruptive technology for left main heart disease, stenting coronary arteries at their branch points. This platform is a paradigm shift in interventional cardiology. The ABS platform is protected by more than 36 ...
based inMulhouse, FRANCE
CellProthera is a biotech company, incorporated in April 2008, and intended for the development, registration and marketing of innovative therapeutic solutions for the regeneration of organs damaged by disease or trauma from autologous blood ...
The unique therapeutic approach proposed by CellProthera is protected by various patents. It requires a simple blood sampling best performed within 2 weeks following a severe AMI. The sampling occurs after a treatment period using GCSF in order to ...
based inHechingen, GERMANY
Bentley is an international medical technology company with headquarters in the South of Germany. At Bentley we are passionate about the development, manufacture and marketing of innovative products for the minimally invasive treatment of vascular ...
This extraordinary product combines a highly flexible one-layer stent graft with a low-profile balloon catheter to offer an unrivalled small guiding catheter compatibility. The cobalt-chrome stent platform is covered with a micro-porous ePTFE ...